Over het archief
Het OWA, het open archief van het Waterbouwkundig Laboratorium heeft tot doel alle vrij toegankelijke onderzoeksresultaten van dit instituut in digitale vorm aan te bieden. Op die manier wil het de zichtbaarheid, verspreiding en gebruik van deze onderzoeksresultaten, alsook de wetenschappelijke communicatie maximaal bevorderen.
Dit archief wordt uitgebouwd en beheerd volgens de principes van de Open Access Movement, en het daaruit ontstane Open Archives Initiative.
Basisinformatie over ‘Open Access to scholarly information'.
Marine bioresource development - Stakeholder's challenges, implementable actions, and business models
Collins, J.E.; Vanagt, T.; Huys, I.; Vieira, H. (2020). Marine bioresource development - Stakeholder's challenges, implementable actions, and business models. Front. Mar. Sci. 7: 62. https://dx.doi.org/10.3389/fmars.2020.00062
In: Frontiers in Marine Science. Frontiers Media: Lausanne. e-ISSN 2296-7745, meer
Is gerelateerd aan:Collins, J.E.; Vanagt, T.; Huys, I.; Vieira, H. (2020). Corrigendum: Marine bioresource development - Stakeholder's challenges, implementable actions, and business models. Front. Mar. Sci. 7: 158. https://dx.doi.org/10.3389/fmars.2020.00158, meer
|   |
| Trefwoord |
|
| Author keywords |
marine biological resources; blue bioeconomy; blue biotechnology;business models; value chain; market; biodiversity; supply andtechnology |
| Auteurs | | Top |
- Collins, J.E., meer
- Vanagt, T., meer
- Huys, I.
- Vieira, H.
|
|
|
| Abstract |
Growth of the blue bioeconomy has potential for contributing positively toward economic growth, societal needs and multiple United Nations Sustainable Development Goals. However, organizations currently experience many challenges which limit success in this field. The aim of this paper is to identify trends in challenges linked to target end markets, stages in the value chain and organization types, to suggest potential solutions and link these to potential novel business models. A survey was completed by 58 organizations representing countries across four continents, and interviews were conducted with seven selected European start-ups/SMEs, to gather information regarding existing bottlenecks and to validate their business model. Results indicate that organizations targeting the pharmaceutical and nutraceutical sector experience a majority of challenges related to supply and technology, whereas organizations targeting the industrial biotechnology or agricultural industry experience more issues linked to market. Both bottom-up and top-down approaches could be applied in order to implement suggested actions. Analysis of the business model canvas used by start-ups/SMEs revealed potential for improvement. In particular, it was noted that review of the 'revenue stream' segment within the business model, specifically regarding alternatives to governmental funding, could be helpful for the long-term survival of these types of organizations. |
IMIS is ontwikkeld en wordt gehost door het VLIZ.
